ACDM News Item

Welcome Boehringer Ingelheim as a new corporate member

Date: February 6, 2024

The ACDM: Association for Clinical Data Management is delighted to welcome Boehringer Ingelheim as a new corporate member.

Boehringer Ingelheim have been transforming lives in healthcare since 1885. They acknowledge the deep and complex ways the lives of humans and animals are interconnected, and work on breakthrough therapies and co-create solutions that help millions of people worldwide live longer, healthier lives.

Members gain many benefits from membership, including:

Access to training courses at a discounted rate
Assign full ACDM membership to all individuals within your organisation
Place an organisation profile, description and logo on the ACDM website
Advertise jobs for your positions within your organisation
Reduced price attendance at conferences and symposia
Free attendance at Hot Topics

Find out more about becoming a corporate member here.

Explore More News

Welcome Mednet as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Mednet as a new . . .

Welcome Allucent as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Allucent as a . . .

Welcome KCR as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome KCR as a new . . .

Welcome Debiopharm as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Debiopharm as a . . .

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025

The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3

As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines

The EMA has opened a public consultation on a reflection paper presenting views . . .

Welcome Instem as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .

Regulatory Considerations Expert Group reviews draft FDA Guidance

The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review

The R&D industry, especially those that are working on clinical trials, have been . . .

Welcome Algorics as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .

Consultation response on legislative proposals for clinical trials

The MHRA have published the public consultation response to the proposals to reform the . . .